Tenderwize
Back to tender search

Open House Originale Rabattverträge 2025-31 - Doravirin

Techniker Krankenkasse·Hamburg, Germany·Deadline Nov 29, 2027 · 468 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-31 - Doravirin

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

40 / 100

Complexity

20 / 100

Risk factors

No estimated contract value, discount rates, or volume commitments. Financial attractiveness unknown.

Contract ends automatically upon patent expiry; if Doravirin patent expires before 30.11.2027, the contract terminates...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Nov 2027
  • Supply of Doravirin pharmaceutical products under discount contracts (Rabattverträge) according to § 130c SGB V.
  • Open House procedure – any eligible pharmaceutical undertaker may join during the contract term.
Show full summary

Open House procedure by Techniker Krankenkasse to conclude discount contracts for the active substance Doravirin. No competition; any eligible pharmaceutical undertaker can join during the contract term (max 24 months, ending 30.11.2027). No estimated value available. No procurement documents analyzed beyond the notice. Notably, the structured data indicates EU funding while the XML notice states no EU funding.

Risks

No estimated contract value, discount rates, or volume commitments. Financial attractiveness unknown.

Contract ends automatically upon patent expiry; if Doravirin patent expires before 30.11.2027, the contract terminates...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical undertaker (pharmazeutischer Unternehmer) as per § 4 Abs. 18 AMG for the offered medicinal product.
  • Must have valid marketing authorization for Doravirin in Germany or be entitled to place the product on the market.

Eligibility

  • Must submit a self-declaration (Anlage 4) confirming eligibility and reliability.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria applicable.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Originale Rabattverträge 2025-31 - Doravirin

Discount contracts for Doravirin. The TK aims to conclude contracts with all suitable pharmaceutical undertakers. No individual negotiations, uniform conditions, non-exclusive. Max 24 months from 01.12.2025 to 30.11.2027. Early termination upon patent expiry.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Nov 2025 - Nov 2027

Category

Pharmaceutical products

Award Criteria

No award criteria applicable.

Deadline

Deadline Nov 29, 2027

Procurement Details

Publication date
12 Oct 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
669486-2025

Documents (1)

Similar tenders